BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1562735)

  • 1. Propagation of human blastic myeloid leukemias in the SCID mouse.
    Sawyers CL; Gishizky ML; Quan S; Golde DW; Witte ON
    Blood; 1992 Apr; 79(8):2089-98. PubMed ID: 1562735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor's disease: an in vivo model of chronic myelogenous leukemia biology.
    Dazzi F; Capelli D; Hasserjian R; Cotter F; Corbo M; Poletti A; Chinswangwatanakul W; Goldman JM; Gordon MY
    Blood; 1998 Aug; 92(4):1390-6. PubMed ID: 9694728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilineage outgrowth of both malignant and normal hemopoietic progenitor cells from individual chronic myeloid leukemia patients in immunodeficient mice.
    Verstegen MM; Cornelissen JJ; Terpstra W; Wagemaker G; Wognum AW
    Leukemia; 1999 Apr; 13(4):618-28. PubMed ID: 10214871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth of human myeloid leukemias in the human marrow environment of SCID-hu mice.
    Namikawa R; Ueda R; Kyoizumi S
    Blood; 1993 Oct; 82(8):2526-36. PubMed ID: 8104540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The severe combined immunodeficient (SCID) mouse as a model for human myeloid leukemias.
    Cesano A; Hoxie JA; Lange B; Nowell PC; Bishop J; Santoli D
    Oncogene; 1992 May; 7(5):827-36. PubMed ID: 1570153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis.
    Sirard C; Lapidot T; Vormoor J; Cashman JD; Doedens M; Murdoch B; Jamal N; Messner H; Addey L; Minden M; Laraya P; Keating A; Eaves A; Lansdorp PM; Eaves CJ; Dick JE
    Blood; 1996 Feb; 87(4):1539-48. PubMed ID: 8608245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engraftment of chronic myeloid leukemia in SCID mice.
    Hoyle CF; Negrin RS
    Hematol Oncol; 1998 Sep; 16(3):87-100. PubMed ID: 10235067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth kinetics and blast-colony forming cell binding capacity of stromal cells in various haematological malignancies.
    el-Khatib Y; Gidáli J; Fehér I; Mód A; Poros A; Hollán S
    Haematologia (Budap); 1991; 24(2):77-82. PubMed ID: 1816058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Thy-1 (CDw90) expression in CD34+ acute leukemia.
    Holden JT; Geller RB; Farhi DC; Holland HK; Stempora LL; Phillips CN; Bray RA
    Blood; 1995 Jul; 86(1):60-5. PubMed ID: 7540889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model of Ph' positive chronic myeloid leukemia-blast crisis cell line growth in immunodeficient SCID mice.
    Skórski T; Nieborowska-Skórska M; Calabretta B
    Folia Histochem Cytobiol; 1992; 30(3):91-6. PubMed ID: 1286728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential growth patterns in SCID mice of patient-derived chronic myelogenous leukemias.
    McGuirk J; Yan Y; Childs B; Fernandez J; Barnett L; Jagiello C; Collins N; O'Reilly RJ
    Bone Marrow Transplant; 1998 Aug; 22(4):367-74. PubMed ID: 9722072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blast crisis in a murine model of chronic myelogenous leukemia.
    Daley GQ; Van Etten RA; Baltimore D
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11335-8. PubMed ID: 1763047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
    Qing X; Qing A; Ji P; French SW; Mason H
    Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow.
    Pear WS; Miller JP; Xu L; Pui JC; Soffer B; Quackenbush RC; Pendergast AM; Bronson R; Aster JC; Scott ML; Baltimore D
    Blood; 1998 Nov; 92(10):3780-92. PubMed ID: 9808572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The receptor tyrosine kinase p185HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia.
    Bühring HJ; Sures I; Jallal B; Weiss FU; Busch FW; Ludwig WD; Handgretinger R; Waller HD; Ullrich A
    Blood; 1995 Sep; 86(5):1916-23. PubMed ID: 7544646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
    Liu YL; Wang XN; Liu HS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
    Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
    Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice.
    Hoyle C; Bangs CD; Chang P; Kamel O; Mehta B; Negrin RS
    Blood; 1998 Nov; 92(9):3318-27. PubMed ID: 9787169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five year leukaemia-free survival of 72% and 77% for early stage acute and chronic myeloid leukaemia treated by HLA-identical sibling bone marrow transplantation.
    Atkinson K; Downs K; Dodds A; Concannon A; Milliken S
    Aust N Z J Med; 1996 Feb; 26(1):54-8. PubMed ID: 8775529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct transplantation of chronic myelogenous leukemia cells into nude mice and establishment of a leukemic stem cell (Ph1+, CD34+) line dependent on mouse bone marrow stromal cells in vitro.
    Kubonishi I; Takeuchi S; Uemura Y; Kamioka M; Asahi Y; Ohtsuki Y; Miyoshi I
    Jpn J Cancer Res; 1995 May; 86(5):451-9. PubMed ID: 7540608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.